John S. Yu
CEO & Chairman
BAS from Stanford, MD from Harvard Medical School and MIT
- Professor of Neurosurgery, Director of Surgical Neuro-Oncology at Cedars-Sinai Medical Center
- Numerous patents for immunotherapies and nanotechnologies from his NIH-funded laboratory
- Developed 8 new investigational drugs with the FDA and has led numerous clinical trials
- Most recently CEO and Chairman of AcTcell, and Director of Enviro Therapeutics
- Immunology Fellowship at the Institute Pasteur, Paris, Neurosurgery Residency at Massachusetts General Hospital/Harvard
